2篇
您的检索式：作者名="Abbas Alshami"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Management of hypertensive crises in the elderly显示文摘高血压的危机比 180/120 mmHg 高是血压的举起。这些能迫切或突现,取决于结束机关损坏的存在。高血压的危机的临床的演讲在老病人是相当可变的,并且临床医生们必须怀疑非特定的症状。在 pathophysiological 的过细的知识在他们改变的老病人需要的设法的高血压的危机,药理学选择,使用的药的 pharmacokinetics,他们的副作用,和他们和另外的药的相互作用。Clevidipine, nicardipine, labetalol, esmolol,和 fenoldopam 在比较喜欢的选择在之中由于他们的功效和 tolerability 老。除非没有可得到的另外的选择, Nitroprusside, hydralazine,和 nifedipine 应该被避免,由于复杂并发症和无法预言的回答的高风险。 | Abbas Alshami Carlos Romero America Avila Joseph Varon | 2018 | Journal of Geriatric Cardiology2018，15，7： | 3 |
| 2 | Gastrointestinal stress ulcer prophylaxis in the intensive care unit,where is the data?显示文摘Stress-induced gastrointestinal ulcers are common among patients admitted to the intensive care unit(ICU).These ulcers impose significant morbidity and mortality,therefore,stress ulcer prophylaxis(SUP) is a common clinical practice among healthcare providers dealing with these critically-ill patients.Several strategies for SUP have been suggested over the past four decades,with acid suppressive therapies being the most commonly used in the ICU.Whether SUP is effective and safe,or not,remains a topic of controversy.The data is still conflicting,and provision of a simple answer is not feasible at the present time.Recently,a large phase IV,multicenter,randomized clinical trial(SUP-ICU),negated the benefits(and harms) of proton pump inhibitors as SUP.This article reviews some of these controversies. | Abbas Alshami Sheily Vianney Barona Joseph Varon Salim Surani | 2019 | World Journal of Meta-Analysis2019，7，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员